Clinical Trial

Comparison Between Treatments of Oligohydramnios

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Based on previous studies, Both sildenafil and L-arginine helped to improve idiopathic oligohydramnios. In this study, Level of improvment of oligohydramnios will be compared. As well as, NICU admission to neonates of pregnancies complicated by idiopathic oligohydramnios. The end goal is to help physicians use the best drug for their patients.
Trial Details
NCT Number NCT07135037
Lead Sponsor Kafrelsheikh University
Conditions Oligohydramnios
Enrollment 40 participants
Start Date 2024-09-01
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-21